Last updated：--
View ChartCapricor Therapeutics Tokenized Stock (Ondo) (CAPRON) is a tokenised equity product issued through the Ondo tokenised asset platform. It provides tokenholders with economic exposure similar to holding shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Any dividends paid on the underlying CAPR shares are intended to be reinvested; no dividends are currently being paid. CAPRON is issued across multiple chains — Solana (primary listing), Ethereum and BNB Chain — with contract addresses 0x70Ec0f5B23404C0cD6f29ce88f4af00A0b0d895D (Ethereum), 0x812Fc2943371C952c6c8Daf99Fe665Eb0e40Cd27 (BNB Chain) and BS8zoc6pmALQnBhBDFak6eFhgGHjpebnHzsxApgondo (Solana). CAPRON enables non-US retail and institutional users to mint and redeem tokenised U.S. stocks and ETFs 24 hours a day, five days a week, with access to traditional exchange liquidity. The product is not issued, sponsored, endorsed, or affiliated with Capricor Therapeutics itself. Circulating supply: approximately 262 CAPRON (total supply 262; no maximum supply cap).
CAPRON is issued through the Ondo tokenised asset platform, which specialises in bringing traditional financial instruments such as U.S. stocks and ETFs on-chain. The underlying company, Capricor Therapeutics, Inc., is a biotechnology firm listed on the Nasdaq Global Select Market under the ticker CAPR. Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapies, with a focus on Duchenne muscular dystrophy. Dr. Marbán (Capricor co-founder) has served as Chief Executive Officer and held a Board seat since November 2013. The tokenised product is issued by Ondo Finance, which operates the Ondo tokenised asset platform; the underlying company is Capricor Therapeutics, Inc. (NASDAQ: CAPR).
CAPRON functions as a tokenised representation of economic exposure to Capricor Therapeutics stock. Users can mint and redeem the tokenised asset through the Ondo platform, with the process designed to mirror the price performance of the underlying NASDAQ-listed equity, including reinvestment of any dividends. The token operates on Ethereum, leveraging its smart-contract infrastructure for issuance, transfer, and settlement. Secondary-market trading runs continuously, seven days a week, while minting and redemption against traditional exchange liquidity operate 24 hours a day, five days a week. The token is subject to additional restrictions and is intended for non-US retail and institutional users.
CAPRON's primary distinction lies in bridging traditional equity markets with blockchain-based settlement. By tokenising a Nasdaq-listed biotechnology stock, it offers global users exposure to Capricor Therapeutics without requiring direct access to U.S. brokerage infrastructure. The product provides continuous price discovery and trading availability beyond standard market hours, and it integrates with the broader Ondo ecosystem of tokenised assets, allowing conversions between CAPRON and other Ondo tokenised instruments such as CLOAon, HIVEon, and CAMTon. This interoperability, combined with Ethereum's established security model, positions CAPRON as part of the growing real-world asset tokenisation sector.
CAPRON is used to gain economic exposure to Capricor Therapeutics, Inc. stock in tokenised form. It allows eligible non-US users to hold and transfer a blockchain-based instrument that tracks the underlying equity, with any dividends reinvested. The token can be traded on supported venues, used in conversion pairs within the Ondo tokenised asset ecosystem, and held in compatible Ethereum wallets. It serves as a tool for portfolio diversification into biotechnology exposure and for participating in the tokenised stocks and real-world assets narrative. The product is not intended for US persons and carries additional restrictions.
The ecosystem around CAPRON is tied to the expansion of Ondo's tokenised asset platform, which continues to add tokenised stocks and ETFs across multiple blockchain categories, including Ethereum, Solana, and BNB Chain. CAPRON is referenced across numerous tracking platforms, converters, and data aggregators, indicating growing integration within the broader tokenised asset infrastructure. The underlying company, Capricor Therapeutics, remains active in clinical development. Capricor's Deramiocel BLA remains under FDA review, with the PDUFA target action date extended as of August 2026. Developments in the underlying equity, such as FDA decisions and clinical data presentations, can influence interest in the tokenised product.
CAPRON is not mined through proof-of-work or staking consensus mechanisms. It is a tokenised asset issued on Ethereum, meaning new tokens are created through minting processes on the Ondo platform rather than through mining. There is no mining hardware, staking requirement, or validator participation associated with acquiring CAPRON. Users obtain the token by minting it through the platform or by purchasing it on supported trading venues. Holding CAPRON does not generate staking rewards or yield by itself.
Store CAPRON in a reputable Ethereum-compatible wallet and safeguard your private keys or seed phrase offline. Because the token exists on Ethereum, standard security practices apply: verify the contract address 0x70ec0f5b23404c0cd6f29ce88f4af00a0b0d895d before interacting, avoid sharing sensitive wallet information, and use hardware wallets for larger holdings. No public audit report for this tokenised product is referenced in available sources; verify the contract address and the issuer's disclosures before interacting. Always conduct independent due diligence and understand the additional restrictions that apply to tokenised stock products before acquiring or holding CAPRON.
Buy in just 4 steps (Register → Verify → Deposit/Purchase → Receive Coins)
Choose Capricor Therapeutics Tokenized Stock (Ondo) products that suit your trading style
Thank you for your interest in BTCC. Currently, spot and futures trading services for CAPRON are not supported. As a leading digital asset platform, BTCC is committed to providing a secure and stable trading environment. We recommend completing your account registration and identity verification (KYC) to explore other premium assets and exclusive benefits available on BTCC.
As of right now, the live price of Capricor Therapeutics Tokenized Stock (Ondo) (CAPRON) is A$13.082228. Its market price fluctuates in real time based on overall supply and demand, and you can check the updated CAPRON to USD rate at the top of BTCC’s price page. In terms of market scope, Capricor Therapeutics Tokenized Stock (Ondo) records a 24h trading volume of A$0 (reflecting total buying and selling activity over the last 24 hours), with a total market cap of A$3.768236K. Its current circulating supply stands at 288.04 out of a maximum supply cap of ∞.
The price volatility of Capricor Therapeutics Tokenized Stock (Ondo) (CAPRON) is essentially driven by market supply and demand dynamics. Key factors behind its price movements include: 1) Global macroeconomic conditions and sentiment, such as Reserve Bank of Australia (RBA) or US Fed interest rate decisions; 2) Tokenomics, including the ratio of circulating supply (288.04) to max supply (∞), as well as token unlocks and burn mechanisms; 3) Fundamental developments, such as ecosystem expansion, on-chain activity, and core protocol upgrades; and 4) Derivatives market dynamics, including leverage battles and liquidation cascades in perpetual contracts.
Looking at its historical price performance, Capricor Therapeutics Tokenized Stock (Ondo) (CAPRON) hit an all-time high (ATH) of A$52.561255 on 2026-04-28 13:45, representing the peak of market sentiment. Conversely, its all-time low (ATL) was recorded at A$4.392661 on 2026-07-30 14:25. Note that historical highs and lows reflect past performance only and do not guarantee future price trends; investment decisions should always align with live market conditions and your personal risk tolerance.
When trading CAPRON futures on BTCC, technical chart analysis begins with identifying key support and resistance levels on 1D and 4H charts using historical price pivots. Next, apply MA/EMA indicators to gauge trend directions, alongside RSI (values above 70 indicate overbought conditions, while below 30 suggest oversold levels). Always validate breakout signals with the 24h trading volume (A$0), as price breakouts accompanied by strong volume offer higher reliability.
Unlike spot trading where you can only profit from rising prices, BTCC’s CAPRONUSDT perpetual contracts support two-way trading. If you anticipate a price decline for Capricor Therapeutics Tokenized Stock (Ondo), simply log into your BTCC account with USDT margin available, navigate to the CAPRONUSDT pair, set your desired leverage and Take-Profit/Stop-Loss levels, and click "Sell/Short". Once the price drops to your target, close your position to lock in profit from the price difference.
Yes. BTCC offers flexible, high-tier leverage options for CAPRONUSDT perpetual futures, providing up to 500x leverage (maximum leverage limits may vary depending on liquidity). While leverage boosts capital efficiency by allowing you to control larger position sizes with less margin, it also amplifies liquidation risks proportionately. BTCC strongly advises using Stop-Loss orders to strictly manage risk when trading with high leverage.
Beginners and traders testing new strategies can switch to BTCC's "Demo Trading" mode with a single click on the App or Web interface. The demo account comes pre-loaded with risk-free virtual funds (such as 100,000 USDT). Powered by live market prices (current price: A$13.082228), you can practise opening/closing positions, adjusting leverage, and setting TP/SL for CAPRONUSDT with zero financial risk.
Trading Capricor Therapeutics Tokenized Stock (Ondo) (CAPRON) on BTCC requires just 4 simple steps: 1) Register a BTCC account and complete basic Identity Verification (KYC); 2) Buy USDT using fiat via credit card/express payment, or deposit USDT/BTC directly from an external wallet; 3) Navigate to the Futures section, search for CAPRONUSDT, and review its live price (A$13.082228) and chart; 4) Select your margin mode and leverage, choose "Buy/Long" or "Sell/Short" based on your market outlook, set TP/SL orders, and confirm your trade.
Cryptocurrency prices are subject to high market risk and price volatility. You should only invest in products that you are familiar with and where you understand the associated risks. The content expressed on this page is not intended to be and shall not be construed as an endorsement by BTCC regarding the reliability or accuracy of such content. You should carefully consider your investment experience, financial situation, investment objectives, and risk tolerance, and consult an independent financial adviser before making any investment. This material should not be construed as financial advice. Past performance is not a reliable indicator of future performance. The value of your investment can go down as well as up, and you may not get back the amount you invested. You are solely responsible for your investment decisions. BTCC is not responsible for any losses you may incur. For more information, please refer to our Terms of Use and Risk Warning. Please also note that data relating to the above-mentioned cryptocurrency presented here (such as its current live price) are based on third-party sources. They are presented to you on an “as is” basis and for informational purposes only, without representation or warranty of any kind. Links provided to third-party sites are also not under BTCC’s control. BTCC is not responsible for the reliability or accuracy of such third-party sites or their contents.
CAPRON/EUR
CAPRON/CAD
CAPRON/GBP
CAPRON/KRW
CAPRON/JPY
CAPRON/AUD
CAPRON/SGD
CAPRON/CHF
CAPRON/INR
CAPRON/TRY
CAPRON/USD
CAPRON/CNY
CAPRON/VND
CAPRON/TWD
CAPRON/NZD
CAPRON/SAR
Bitcoin
Ethereum
Tether USDt
BNB
XRP
Solana
Dogecoin
Cardano
Avalanche
